Philadelphia’s soaring life sciences commercial real estate market is being driven by the combination of strong demand for advanced lab and manufacturing facilities and near record low vacancy rates.
In 2020 we introduced a new series titled “5 Questions With…” in an effort to spotlight individuals from across the BioHealth Capital Region and beyond. Providing this platform has allowed us to help share the stories of industry peers and show that there isn’t a single “right” way to becoming an industry success.
Andrew Davis is Vice President at Scheer Partners and helps run the scientific real estate practice. Andrew lives in Maryland but assists scientific companies identify, negotiate, and build space in the Biohealth Capital Region, Philadelphia / Greater PA, and Massachusetts.
Top 10 Biotech News Stories from 2019 from the BioHealth Capital Region on biobuzz.io
Maryland BioHealth Leaders Come Together to Share Solutions for Attracting & Retaining Top Talent October 1, 2019 Attracting talent is one of the most commonly cited challenges voiced by company [….]
A Uniquely Positioned GMP BioManufacturing Facility Hits the Market in Maryland Biotech is booming across the country, especially in the top biotech clusters like Boston, San Francisco, New York and [….]
BioBuzz Panel on Drug Development in Rare Diseases with regional leaders from AstraZeneca, REGENXBIO, American Gene Technologies, GeneDx and Jeeva Informatics
New Lab Space Designed to Attract Biotech Talent and Community Opens at 704 Quince Orchard Next Generation Lab Building completes the Gaithersburg Life Sciences Cluster February 6, 2019 When construction [….]
BioTalk Podcast with Matt Brady, Vice President at Scheer Partners This episode of BioTalk really shed some light on the real estate market for lab space in the region, and what that [….]
